234 related articles for article (PubMed ID: 17640970)
1. RAGE expression in rhabdomyosarcoma cells results in myogenic differentiation and reduced proliferation, migration, invasiveness, and tumor growth.
Riuzzi F; Sorci G; Donato R
Am J Pathol; 2007 Sep; 171(3):947-61. PubMed ID: 17640970
[TBL] [Abstract][Full Text] [Related]
2. The amphoterin (HMGB1)/receptor for advanced glycation end products (RAGE) pair modulates myoblast proliferation, apoptosis, adhesiveness, migration, and invasiveness. Functional inactivation of RAGE in L6 myoblasts results in tumor formation in vivo.
Riuzzi F; Sorci G; Donato R
J Biol Chem; 2006 Mar; 281(12):8242-53. PubMed ID: 16407300
[TBL] [Abstract][Full Text] [Related]
3. Amphoterin stimulates myogenesis and counteracts the antimyogenic factors basic fibroblast growth factor and S100B via RAGE binding.
Sorci G; Riuzzi F; Arcuri C; Giambanco I; Donato R
Mol Cell Biol; 2004 Jun; 24(11):4880-94. PubMed ID: 15143181
[TBL] [Abstract][Full Text] [Related]
4. Cross-talk between MAP kinase pathways is involved in IGF-independent, IGFBP-6-induced Rh30 rhabdomyosarcoma cell migration.
Fu P; Liang GJ; Khot SS; Phan R; Bach LA
J Cell Physiol; 2010 Sep; 224(3):636-43. PubMed ID: 20432455
[TBL] [Abstract][Full Text] [Related]
5. Differential effects between amphoterin and advanced glycation end products on colon cancer cells.
Kuniyasu H; Chihara Y; Kondo H
Int J Cancer; 2003 May; 104(6):722-7. PubMed ID: 12640679
[TBL] [Abstract][Full Text] [Related]
6. High-mobility group box-B1 (HMGB1) mediates the hypoxia-induced mesenchymal transition of osteoblast cells via activating ERK/JNK signaling.
Qiu Y; Chen Y; Zeng T; Guo W; Zhou W; Yang X
Cell Biol Int; 2016 Nov; 40(11):1152-1161. PubMed ID: 27106169
[TBL] [Abstract][Full Text] [Related]
7. Extracellular HMGB1 released by NMDA treatment confers neuronal apoptosis via RAGE-p38 MAPK/ERK signaling pathway.
Kim SW; Lim CM; Kim JB; Shin JH; Lee S; Lee M; Lee JK
Neurotox Res; 2011 Aug; 20(2):159-69. PubMed ID: 21116767
[TBL] [Abstract][Full Text] [Related]
8. H-Ras-specific activation of Rac-MKK3/6-p38 pathway: its critical role in invasion and migration of breast epithelial cells.
Shin I; Kim S; Song H; Kim HR; Moon A
J Biol Chem; 2005 Apr; 280(15):14675-83. PubMed ID: 15677464
[TBL] [Abstract][Full Text] [Related]
9. Receptor for advanced glycation end products (RAGE) partially mediates HMGB1-ERKs activation in clear cell renal cell carcinoma.
Lin L; Zhong K; Sun Z; Wu G; Ding G
J Cancer Res Clin Oncol; 2012 Jan; 138(1):11-22. PubMed ID: 21947243
[TBL] [Abstract][Full Text] [Related]
10. High-Mobility Group Box 1 (HMGB1) Induces Migration of Endothelial Progenitor Cell via Receptor for Advanced Glycation End-Products (RAGE)-Dependent PI3K/Akt/eNOS Signaling Pathway.
Zhang Y; You B; Liu X; Chen J; Peng Y; Yuan Z
Med Sci Monit; 2019 Aug; 25():6462-6473. PubMed ID: 31461437
[TBL] [Abstract][Full Text] [Related]
11. S100B engages RAGE or bFGF/FGFR1 in myoblasts depending on its own concentration and myoblast density. Implications for muscle regeneration.
Riuzzi F; Sorci G; Beccafico S; Donato R
PLoS One; 2012; 7(1):e28700. PubMed ID: 22276098
[TBL] [Abstract][Full Text] [Related]
12. Blockade of Rac1 activity induces G1 cell cycle arrest or apoptosis in breast cancer cells through downregulation of cyclin D1, survivin, and X-linked inhibitor of apoptosis protein.
Yoshida T; Zhang Y; Rivera Rosado LA; Chen J; Khan T; Moon SY; Zhang B
Mol Cancer Ther; 2010 Jun; 9(6):1657-68. PubMed ID: 20515940
[TBL] [Abstract][Full Text] [Related]
13. Akt2, a novel functional link between p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways in myogenesis.
Gonzalez I; Tripathi G; Carter EJ; Cobb LJ; Salih DA; Lovett FA; Holding C; Pell JM
Mol Cell Biol; 2004 May; 24(9):3607-22. PubMed ID: 15082758
[TBL] [Abstract][Full Text] [Related]
14. HMGB1 mediates invasion and PD-L1 expression through RAGE-PI3K/AKT signaling pathway in MDA-MB-231 breast cancer cells.
Amornsupak K; Thongchot S; Thinyakul C; Box C; Hedayat S; Thuwajit P; Eccles SA; Thuwajit C
BMC Cancer; 2022 May; 22(1):578. PubMed ID: 35610613
[TBL] [Abstract][Full Text] [Related]
15. Receptor for advanced glycation end products (RAGE) mediates neuronal differentiation and neurite outgrowth.
Wang L; Li S; Jungalwala FB
J Neurosci Res; 2008 May; 86(6):1254-66. PubMed ID: 18058943
[TBL] [Abstract][Full Text] [Related]
16. p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells.
Ciccarelli C; Marampon F; Scoglio A; Mauro A; Giacinti C; De Cesaris P; Zani BM
Mol Cancer; 2005 Dec; 4():41. PubMed ID: 16351709
[TBL] [Abstract][Full Text] [Related]
17. Defective RAGE activity in embryonal rhabdomyosarcoma cells results in high PAX7 levels that sustain migration and invasiveness.
Chiappalupi S; Riuzzi F; Fulle S; Donato R; Sorci G
Carcinogenesis; 2014 Oct; 35(10):2382-92. PubMed ID: 25123133
[TBL] [Abstract][Full Text] [Related]
18. Emodin inhibits tumor cell migration through suppression of the phosphatidylinositol 3-kinase-Cdc42/Rac1 pathway.
Huang Q; Shen HM; Ong CN
Cell Mol Life Sci; 2005 May; 62(10):1167-75. PubMed ID: 15928809
[TBL] [Abstract][Full Text] [Related]
19. Nilotinib impairs skeletal myogenesis by increasing myoblast proliferation.
Contreras O; Villarreal M; Brandan E
Skelet Muscle; 2018 Feb; 8(1):5. PubMed ID: 29463296
[TBL] [Abstract][Full Text] [Related]
20. C-reactive protein (CRP) up-regulates expression of receptor for advanced glycation end products (RAGE) and its inflammatory ligand EN-RAGE in THP-1 cells: inhibitory effects of atorvastatin.
Mahajan N; Bahl A; Dhawan V
Int J Cardiol; 2010 Jul; 142(3):273-8. PubMed ID: 19201044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
